Merck said it still doesn’t know the full magnitude of the impact of the attack, and that it can’t put a number on the financial hit yet, but that some manufacturing operations are still offline. Specifically, the company can’t fulfill some orders in some markets, and remains incapable of bulk production within its Active Pharmaceutical Ingredient operations.

Read full news article on Infosecurity